TY  - JOUR
AU  - Rueda-Gotor, Javier
AU  - Lopez-Mejias, Raquel
AU  - Remuzgo-Martinez, Sara
AU  - Pulito-Cueto, Veronica
AU  - Corrales, Alfonso
AU  - Lera-Gomez, Leticia
AU  - Portilla, Virginia
AU  - Gonzalez-Mazon, Iñigo
AU  - Blanco, Ricardo
AU  - Exposito, Rosa
AU  - Mata, Cristina
AU  - Llorca, Javier
AU  - Hernandez-Hernandez, Vanesa
AU  - Rodriguez-Lozano, Carlos
AU  - Barbarroja, Nuria
AU  - Castro, Rafaela Ortega
AU  - Vicente, Esther
AU  - Fernandez-Carballido, Cristina
AU  - Martinez-Vidal, Maria Paz
AU  - Castro-Corredor, David
AU  - Anino-Fernandez, Joaquin
AU  - Peiteado, Diana
AU  - Plasencia-Rodriguez, Chamaida
AU  - Galindez-Agirregoikoa, Eva
AU  - García-Vivar, María Luz
AU  - Gualillo, Oreste
AU  - Quevedo-Abeledo, Juan Carlos
AU  - Castañeda, Santos
AU  - Ferraz-Amaro, Ivan
AU  - Gonzalez-Gay, Miguel A
AU  - Genre, Fernanda
PY  - 2021
DO  - 10.1186/s13075-021-02499-7
UR  - http://hdl.handle.net/10668/17571
T2  - Arthritis research & therapy
AB  - Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from axial spondyloarthritis (axSpA). Given the high incidence of CV disease (mainly due to...
LA  - en
PB  - BioMed Central
KW  - Axial spondyloarthritis
KW  - Biomarker
KW  - Cardiovascular risk
KW  - Polymorphism
KW  - Subclinical atherosclerosis
KW  - Vaspin
KW  - Atherosclerosis
KW  - Cardiovascular diseases
KW  - Female
KW  - Heart disease risk factors
KW  - Humans
KW  - Male
KW  - Risk factors
KW  - Serpins
KW  - Spondylarthritis
TI  - Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study.
TY  - Research article
VL  - 23
ER  -